lactic acid and finasteride

lactic acid has been researched along with finasteride in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's2 (33.33)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Isotalo, T; Talja, M; Tammela, TL; Törmälä, P; Välimaa, T1
Hellström, P; Isotalo, T; Perttilä, I; Talja, M; Tammela, TL; Törmälä, P; Välimaa, T1
Ahmed, OA; Hussein, AK; Mady, FM1
Cruz, N; Dias, IS; Rebelo, A; Reis, CP; Rijo, P; Roberto, A; Roque, LV1
Cho, HY; Choi, GW; Chon, CH; Kang, DW; Kim, JH; Kim, S; Ryu, CH1
Bozkurt, MF; Erbas, O; Ozkul, B; Sever, IH1

Trials

1 trial(s) available for lactic acid and finasteride

ArticleYear
A double-blind, randomized, placebo-controlled pilot study to investigate the effects of finasteride combined with a biodegradable self-reinforced poly L-lactic acid spiral stent in patients with urinary retention caused by bladder outlet obstruction from
    BJU international, 2001, Volume: 88, Issue:1

    Topics: Absorbable Implants; Aged; Aged, 80 and over; Combined Modality Therapy; Double-Blind Method; Enzyme Inhibitors; Finasteride; Humans; Lactic Acid; Male; Middle Aged; Pilot Projects; Polyesters; Polymers; Prostatic Hyperplasia; Stents; Treatment Outcome; Urinary Bladder Neck Obstruction; Urinary Retention

2001

Other Studies

5 other study(ies) available for lactic acid and finasteride

ArticleYear
A pilot study of a bioabsorbable self-reinforced poly L-lactic acid urethral stent combined with finasteride in the treatment of acute urinary retention from benign prostatic enlargement.
    BJU international, 2000, Volume: 85, Issue:1

    Topics: Acute Disease; Aged; Aged, 80 and over; Ambulatory Care; Combined Modality Therapy; Enzyme Inhibitors; Finasteride; Humans; Lactic Acid; Male; Middle Aged; Pilot Projects; Polyesters; Polymers; Prostatic Hyperplasia; Stents; Urinary Retention; Urination

2000
Optimisation of microstructured biodegradable finasteride formulation for depot parenteral application.
    Journal of microencapsulation, 2016, Volume: 33, Issue:3

    Topics: Animals; Biocompatible Materials; Caproates; Delayed-Action Preparations; Drug Compounding; Finasteride; Humans; Injections; Lactic Acid; Lactones; Male; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prostatic Hyperplasia; Rabbits; Urological Agents

2016
Design of Finasteride-Loaded Nanoparticles for Potential Treatment of Alopecia.
    Skin pharmacology and physiology, 2017, Volume: 30, Issue:4

    Topics: 5-alpha Reductase Inhibitors; Adult; Alopecia; Cosmetics; Drug Carriers; Drug Liberation; Female; Finasteride; Humans; Lactic Acid; Nanoparticles; Particle Size; Poloxamer; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Saccharomyces cerevisiae; Skin; Skin Tests; Young Adult

2017
Pharmacokinetic-pharmacodynamic modeling approach for dose prediction of the optimal long-acting injectable formulation of finasteride.
    International journal of pharmaceutics, 2021, May-15, Volume: 601

    Topics: Animals; Chromatography, Liquid; Delayed-Action Preparations; Dogs; Finasteride; Lactic Acid; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Tandem Mass Spectrometry

2021
Therapeutic effect of finasteride through its antiandrogenic and antioxidant role in a propionic acid-induced autism model: Demonstrated by behavioral tests, histological findings and MR spectroscopy.
    Neuroscience letters, 2022, 05-14, Volume: 779

    Topics: Animals; Antioxidants; Autistic Disorder; Behavior Rating Scale; Creatine; Finasteride; Lactic Acid; Magnetic Resonance Spectroscopy; Propionates; Quality of Life; Rats

2022